C. Xu

3.0k total citations
184 papers, 1.7k citations indexed

About

C. Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, C. Xu has authored 184 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 86 papers in Oncology and 53 papers in Molecular Biology. Recurrent topics in C. Xu's work include Lung Cancer Treatments and Mutations (95 papers), Lung Cancer Research Studies (32 papers) and Cancer Genomics and Diagnostics (26 papers). C. Xu is often cited by papers focused on Lung Cancer Treatments and Mutations (95 papers), Lung Cancer Research Studies (32 papers) and Cancer Genomics and Diagnostics (26 papers). C. Xu collaborates with scholars based in China, United States and Taiwan. C. Xu's co-authors include Wenxian Wang, You‐cai Zhu, Zhengbo Song, Huafei Chen, Wu Zhuang, Kaiqi Du, Meiyu Fang, Yong Song, Tangfeng Lv and Lixin Wu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

C. Xu

164 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Xu China 22 945 795 589 471 203 184 1.7k
Andrea Napolitano Italy 22 1.1k 1.2× 486 0.6× 438 0.7× 330 0.7× 157 0.8× 72 1.9k
Wei Zhong China 21 802 0.8× 687 0.9× 275 0.5× 370 0.8× 336 1.7× 122 1.4k
Nicolas Guibert France 25 1.2k 1.3× 866 1.1× 476 0.8× 957 2.0× 261 1.3× 87 1.9k
Elizabeth Fabre France 22 583 0.6× 725 0.9× 441 0.7× 367 0.8× 127 0.6× 91 1.5k
Kim Ely United States 20 447 0.5× 585 0.7× 699 1.2× 379 0.8× 476 2.3× 51 2.0k
Yu Sun China 20 380 0.4× 553 0.7× 456 0.8× 311 0.7× 205 1.0× 93 1.5k
Liyan Xue China 26 807 0.9× 515 0.6× 642 1.1× 322 0.7× 734 3.6× 137 1.9k
Tsutomu Iwasa Japan 23 539 0.6× 765 1.0× 455 0.8× 187 0.4× 175 0.9× 82 1.5k
Hisatsugu Goto Japan 26 752 0.8× 558 0.7× 554 0.9× 276 0.6× 104 0.5× 74 1.6k
Jia-Lin Lee South Korea 21 503 0.5× 892 1.1× 919 1.6× 344 0.7× 335 1.7× 50 2.0k

Countries citing papers authored by C. Xu

Since Specialization
Citations

This map shows the geographic impact of C. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Xu more than expected).

Fields of papers citing papers by C. Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Xu. The network helps show where C. Xu may publish in the future.

Co-authorship network of co-authors of C. Xu

This figure shows the co-authorship network connecting the top 25 collaborators of C. Xu. A scholar is included among the top collaborators of C. Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Xu. C. Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jianhui, et al.. (2024). Distributed multienergy and low-carbon heating technology for rural areas in northern China. Energy. 307. 132778–132778.
2.
Sun, Xiaofeng, Hao Song, Xiaoran Sun, et al.. (2024). A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma. Cancer Investigation. 42(3). 226–242.
3.
4.
Chen, Jiayan, Yueyue Song, Yingshui Yao, et al.. (2024). Co-Delivery of VEGF siRNA and THPP via Metal–Organic Framework Reverses Cisplatin-Resistant Non-Small Cell Lung Cancer and Inhibits Metastasis through a MUC4 Regulating Mechanism. ACS Applied Materials & Interfaces. 16(42). 56910–56925. 4 indexed citations
5.
Lv, Donglai, et al.. (2023). [Lung Squamous Cell Carcinoma with EML4-ALK Fusion and TP53 Co-mutation 
Treated with Ensartinib: A Case Report and Literature Review].. SHILAP Revista de lepidopterología. 26(1). 78–82. 3 indexed citations
6.
Xu, C., et al.. (2023). A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma. The Clinical Respiratory Journal. 17(12). 1349–1360. 1 indexed citations
7.
Chen, Jiayan, C. Xu, Qian Wang, et al.. (2023). Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study. Lung Cancer. 183. 107315–107315. 6 indexed citations
8.
Feng, Weineng, Zihao Chen, Junwei Su, et al.. (2023). Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer. Lung Cancer. 178. 66–74. 11 indexed citations
9.
Wang, Wenxian, Gen Lin, Yue Hao, et al.. (2022). Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study. European Journal of Cancer. 174. 21–30. 10 indexed citations
10.
Zhang, Yongchang, Zhe Huang, Liang Zeng, et al.. (2022). Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements. npj Precision Oncology. 6(1). 20–20. 11 indexed citations
11.
Song, Zhengbo, Dongqing Lv, Shiqing Chen, et al.. (2021). Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial. Clinical Cancer Research. 28(3). 461–467. 31 indexed citations
12.
13.
Chen, Dong, Xingliang Li, Wu B, et al.. (2020). A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib. Frontiers in Oncology. 10. 867–867. 10 indexed citations
14.
15.
Xu, C., W. Wang, Wei Zhuang, et al.. (2018). P1.03-27 Somatic Mutations in BRCA2 Genes Are Associated with Prognosis in Chinese Non-Small-Cell Lung Cancer Patients. Journal of Thoracic Oncology. 13(10). S522–S522. 2 indexed citations
16.
Xu, C., W. Wang, Wei Zhuang, et al.. (2018). P3.03-09 Molecular Spectrum of KIT Mutations Detection in Chinese Non-Small Cell Lung Cancer Patients. Journal of Thoracic Oncology. 13(10). S913–S914. 1 indexed citations
17.
Xu, C., W. Wang, Wu Zhuang, et al.. (2018). P1.03-25 The Frequency and Prognosis of ATM Mutations in Chinese Non-Small-Cell Lung Cancer Patients. Journal of Thoracic Oncology. 13(10). S521–S521. 1 indexed citations
18.
19.
Xu, C., W. Wang, Wei Zhuang, et al.. (2018). P1.03-01 Association of APC Mutations with Chinese Patients Molecular Spectrum in Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S512–S512. 2 indexed citations
20.
Li, Hua, et al.. (2016). OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway. Journal of Korean Medical Science. 31(8). 1215–1215. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Napolitano Breakdown of academic impact, for papers by Wei Zhong Breakdown of academic impact, for papers by Nicolas Guibert Breakdown of academic impact, for papers by Elizabeth Fabre Breakdown of academic impact, for papers by Kim Ely Breakdown of academic impact, for papers by Yu Sun Breakdown of academic impact, for papers by Liyan Xue Breakdown of academic impact, for papers by Tsutomu Iwasa Breakdown of academic impact, for papers by Hisatsugu Goto Breakdown of academic impact, for papers by Jia-Lin Lee
Rankless by CCL
2026